LD-2 disclosure · 2nd Quarter - Report
PARKINSON'S ACTION NETWORK
Coverage · No income or expenses were reported on this filing.
Client
- Location
- District of Columbia · United States of America
Registrant
- Description
- Medical/Disease Research/Clinical Labs
- Location
- Washington, District of Columbia, United States of America
Lobbying activities
1 issueMedical/Disease Research/Clinical Labs
H.R. 2595/S.425, "The National Neurological Diseases Surveillance System Act" all sections; "Department of Labor, Health and Human Services, Education and Related Agencies Appropriations," all sections relating to the National Institutes of Health (NIH); "Department of Defense Appropriations," section related to the Neurotoxin Exposure Treatment Parkinson's Research (NETPR) program; H.R. 1546/S.829, "The Medicare Access to Rehabilitation Services Act of 2011" all sections; H.R. 4132, "The Faster Access to Specialized Treatments Act of 2011" all sections; S. 2113 "The Transforming the Regulatory Environment to Accelerate Access to Treatment of 2011" all sections; S. 3187 "The Food and Drug Administration Safety and Innovation Act" all sections;
LobbyistsCATHERINE PUGH · ms REBECCA W O'CONNOR · TIMOTHY JOHNSON
TargetedSENATE · HOUSE OF REPRESENTATIVES